About the journal
Journal of Circulating Biomarkers is an open-access journal published by AboutScience Srl in Italy, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,500 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- AboutScience Srl
- ISSN
- 1849-4544
- Country
- Italy
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,500 EUR
- Articles in DOAJ
- 90
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.aboutscience.eu/index.php/jcb
Index listings
- DOAJ · 2016-01-02
- Indexing
- DOAJ
- APC
- 1,500 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
90
Most recent article
6 years ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
172
Last recorded publication year
2026
h-index
24
i10-index
50
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2020-08-11
- Added to DOAJ
- 2016-01-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 38%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101703517
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Show all subjects (50)
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Cardiovascular Disease and Adiposity
- Cardiovascular Disease and Adiposity
- COVID-19 Clinical Research Studies
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Prostate Cancer Treatment and Research
- COVID-19 Clinical Research Studies
- Prostate Cancer Treatment and Research
- Parathyroid Disorders and Treatments
- Liver Disease Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Hepatocellular Carcinoma Treatment and Prognosis
- Nutrition and Health in Aging
- Parathyroid Disorders and Treatments
- GDF15 and Related Biomarkers
- Monoclonal and Polyclonal Antibodies Research
- Metabolomics and Mass Spectrometry Studies
- Microfluidic and Bio-sensing Technologies
- IL-33, ST2, and ILC Pathways
- Metabolomics and Mass Spectrometry Studies
- Circular RNAs in diseases
- Cancer Immunotherapy and Biomarkers
- Microfluidic and Bio-sensing Technologies
- IL-33, ST2, and ILC Pathways
- GDF15 and Related Biomarkers
- Nutrition and Health in Aging
- Advanced Proteomics Techniques and Applications
- Advanced Proteomics Techniques and Applications
- Adipokines, Inflammation, and Metabolic Diseases
- Hepatocellular Carcinoma Treatment and Prognosis
- Prostate Cancer Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Dialysis and Renal Disease Management
- Liver Disease Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- RNA Research and Splicing
- Prostate Cancer Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Dialysis and Renal Disease Management
- Lung Cancer Treatments and Mutations
Keywords (DOAJ)
- circulating biomarkers
- extracellular vesicles
- circulating cell-free dna (cfdna)
- exosomes
- circulating tumour cells (ctc)
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ